Literature DB >> 22890722

Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.

Neil Shah1, Jochen Kammermeier, Mamoun Elawad, Erik-Oliver Glocker.   

Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease characterized by abdominal pain, bloody diarrhoea, and malabsorption leading to weight loss. It is considered the result of inadequate control of an excessive reaction of the immune system to the resident flora of the gut. Like other primary immunodeficiencies, IL-10 and IL-10 receptor (IL10R) deficiency present with IBD and demonstrate the sensitivity of the intestine to any changes of the immune system. Both IL-10 and IL10R deficiency cause severe early-onset enterocolitis and can be successfully treated by hematopoietic stem cell transplantation (HSCT).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890722     DOI: 10.1007/s11882-012-0286-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  61 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.

Authors:  Catherine Van Montfrans; Maria Sol Rodriguez Pena; Inge Pronk; Fiebo J W Ten Kate; Anje A Te Velde; Sander J H Van Deventer
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

4.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 5.  The genetics of Crohn's disease.

Authors:  Johan Van Limbergen; David C Wilson; Jack Satsangi
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

6.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

7.  Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.

Authors:  S Schreiber; T Heinig; H G Thiele; A Raedler
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

Review 8.  The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain.

Authors:  Raymond P Donnelly; Faruk Sheikh; Sergei V Kotenko; Harold Dickensheets
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

9.  Inflammatory skin and bowel disease linked to ADAM17 deletion.

Authors:  Diana C Blaydon; Paolo Biancheri; Wei-Li Di; Vincent Plagnol; Rita M Cabral; Matthew A Brooke; David A van Heel; Franz Ruschendorf; Mark Toynbee; Amanda Walne; Edel A O'Toole; Joanne E Martin; Keith Lindley; Tom Vulliamy; Dominic J Abrams; Thomas T MacDonald; John I Harper; David P Kelsell
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  41 in total

Review 1.  The Role of Neuropeptides in Mouse Models of Colitis.

Authors:  David Padua; John P Vu; Patrizia M Germano; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2015-12-08       Impact factor: 3.444

Review 2.  Pathway-based approaches to the treatment of inflammatory bowel disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Transl Res       Date:  2015-09-07       Impact factor: 7.012

Review 3.  Significant roles played by IL-10 in Chlamydia infections.

Authors:  Hamid Hakimi; Mohammad Zare-Bidaki; Nahid Zainodini; Shokrollah Assar; Mohammad Kazemi Arababadi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.

Authors:  Yuan Xiao; Xin-Qiong Wang; Yi Yu; Yan Guo; Xu Xu; Ling Gong; Tong Zhou; Xiao-Qin Li; Chun-Di Xu
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 5.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  A Comparison of the Anti-Inflammatory Effects of Cis-9, Trans-11 Conjugated Linoleic Acid to Celecoxib in the Collagen-Induced Arthritis Model.

Authors:  Jake M Olson; Alexander W Haas; Jennifer Lor; Holly S McKee; Mark E Cook
Journal:  Lipids       Date:  2017-01-11       Impact factor: 1.880

Review 7.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

8.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 9.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409

Review 10.  The microbial basis of inflammatory bowel diseases.

Authors:  Sushila R Dalal; Eugene B Chang
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.